Products & Services · Foreign currency translation and other

Cancer — Foreign currency translation and other

Aflac Cancer — Foreign currency translation and other decreased by 163.9% to -$62.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 138.8%, from $160.00M to -$62.00M.

Analysis

StatementSegment
CategoryRisk
SignalContext dependent
VolatilityVolatile
First reportedQ1 2022
Last reportedQ1 2026May 6, 2026

How to read this metric

Large fluctuations indicate high exposure to foreign currency risk, which can obscure underlying operational performance.

Detailed definition

Captures the impact of fluctuations in exchange rates on the valuation of assets and liabilities within the cancer segme...

Peer comparison

Common for multinational insurers; peers with significant Japanese or international exposure report similar translation impacts.

Metric ID: afl_segment_cancer_foreign_currency_translation_and_other

Historical Data

13 periods
 Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q4 '24Q1 '25Q2 '25Q1 '26
Value-$133.00M-$133.00M-$133.00M-$133.00M-$19.00M-$243.00M-$90.00M-$189.00M-$169.00M-$297.00M$160.00M$97.00M-$62.00M
QoQ Change+0.0%+0.0%+0.0%+85.7%<-999%+63.0%-110.0%+10.6%-75.7%+153.9%-39.4%-163.9%
YoY Change+85.7%-82.7%+32.3%-894.7%+30.5%+184.7%+157.4%-138.8%
Range-$297.00M$160.00M
CAGR-22.5%
Avg YoY Growth-78.2%
Median YoY Growth+31.4%
Current Streak2 quarters decline

Frequently Asked Questions

What is Aflac's cancer — foreign currency translation and other?
Aflac (AFL) reported cancer — foreign currency translation and other of -$62.00M in Q1 2026.
How has Aflac's cancer — foreign currency translation and other changed year-over-year?
Aflac's cancer — foreign currency translation and other decreased by 138.8% year-over-year, from $160.00M to -$62.00M.
What does cancer — foreign currency translation and other mean?
The net impact of currency exchange rate changes on the segment's financial position.